Newsletter | 01 September 2003 Access News 9, Focus on South Africa, September 2003 INTELLECTUAL PROPERTY AND TRADE This editions focus is on South Africa and the changing times, understanding patents, the Free Trade Area of the Americas, the ups and downs of the pharma industry and the G8s betrayal of people in developing countries. Read, watch, share Filter by - Any -BlogEventsFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePress releaseReportResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Photo credit: Mudit Mathur Press release Press release | 05 March 2026 Intellectual property and trade EuropeIndia DNP+ and MSF welcome the removal of harmful IP provisions in EU-India FTA , but call for continued vigilance 4 min 19 November 2025 Intellectual property and trade CanadaUnited States of America MSF urges reform of United States-Mexico-Canada Agreement's (USMCA) pharmaceutical intellectual property provisions to safeguard public health Photograph by Diogo Galvão Press release Press release | 03 September 2025 Intellectual property and trade Brazil MSF warns that US trade pressure may interfere with access to medicines in Brazil 5 min Technical brief | 03 July 2025 HIV/AIDS Intellectual property and trade Gilead’s Voluntary License on Lenacapavir: Key Limitations of the License and Recommendations to Improve Access Photograph by Valérie Batselaere Statement Statement | 23 January 2025 Pandemic preparedness Antimicrobial resistance Intellectual property and trade Research and development Tropical & neglected diseases Vaccines MSF statement on US decision to withdraw from WHO Press release | 05 July 2024 Intellectual property and trade Tuberculosis South Africa MSF and Health Justice Initiative welcome J&J’s withdrawal of patents on lifesaving TB drug in South Africa Photo credit: Marta Soszynska/MSF Press release Press release | 24 April 2024 HIV/AIDS Intellectual property and trade Colombia issues first-ever compulsory license, a landmark step for expanding access to affordable HIV treatment 4 min Photo credit: Mudit Mathur Technical brief Technical brief | 12 March 2024 Intellectual property and trade SwitzerlandIndia MSF Comments on intellectual property provisions in the final agreement of India-EFTA Agreement 1 min Load More
Photo credit: Mudit Mathur Press release Press release | 05 March 2026 Intellectual property and trade EuropeIndia DNP+ and MSF welcome the removal of harmful IP provisions in EU-India FTA , but call for continued vigilance 4 min
19 November 2025 Intellectual property and trade CanadaUnited States of America MSF urges reform of United States-Mexico-Canada Agreement's (USMCA) pharmaceutical intellectual property provisions to safeguard public health
Photograph by Diogo Galvão Press release Press release | 03 September 2025 Intellectual property and trade Brazil MSF warns that US trade pressure may interfere with access to medicines in Brazil 5 min
Technical brief | 03 July 2025 HIV/AIDS Intellectual property and trade Gilead’s Voluntary License on Lenacapavir: Key Limitations of the License and Recommendations to Improve Access
Photograph by Valérie Batselaere Statement Statement | 23 January 2025 Pandemic preparedness Antimicrobial resistance Intellectual property and trade Research and development Tropical & neglected diseases Vaccines MSF statement on US decision to withdraw from WHO
Press release | 05 July 2024 Intellectual property and trade Tuberculosis South Africa MSF and Health Justice Initiative welcome J&J’s withdrawal of patents on lifesaving TB drug in South Africa
Photo credit: Marta Soszynska/MSF Press release Press release | 24 April 2024 HIV/AIDS Intellectual property and trade Colombia issues first-ever compulsory license, a landmark step for expanding access to affordable HIV treatment 4 min
Photo credit: Mudit Mathur Technical brief Technical brief | 12 March 2024 Intellectual property and trade SwitzerlandIndia MSF Comments on intellectual property provisions in the final agreement of India-EFTA Agreement 1 min
